These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26721305)

  • 1. Urothelial Carcinoma With Villoglandular Differentiation: A Rare Entity.
    Mitra S; Sundaram AK; Gupta K; Devana SK
    Int J Surg Pathol; 2016 Jun; 24(4):356-9. PubMed ID: 26721305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transition between urothelial carcinoma in situ and non-invasive micropapillary carcinoma as a pivot connection between diverse morphologies of bladder carcinoma: a case report of urothelial carcinoma with villoglandular differentiation.
    Tajima S; Koda K
    Int J Clin Exp Pathol; 2015; 8(3):3288-93. PubMed ID: 26045854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdoid variant of urothelial carcinoma of the urinary bladder: a case report with emphasis on immunohistochemical analysis regarding the formation of rhabdoid morphology.
    Tajima S
    Int J Clin Exp Pathol; 2015; 8(8):9638-42. PubMed ID: 26464730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD138 Expression Is Observed in the Urothelial Epithelium and in Various Urothelial Carcinomas, and Cannot Be Evidence for Plasmacytoid Urothelial Carcinoma.
    Goto K
    Int J Surg Pathol; 2016 Oct; 24(7):614-9. PubMed ID: 27305940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical stains to detect residual tumor in cystectomy specimens taken shortly after transurethral resection of bladder tumors.
    Barresi V; Nunnari CM; Lionti S
    Ann Diagn Pathol; 2019 Jun; 40():176-179. PubMed ID: 30266536
    [No Abstract]   [Full Text] [Related]  

  • 6. A combination of p40, GATA-3 and uroplakin II shows utility in the diagnosis and prognosis of muscle-invasive urothelial carcinoma.
    Leivo MZ; Elson PJ; Tacha DE; Delahunt B; Hansel DE
    Pathology; 2016 Oct; 48(6):543-9. PubMed ID: 27594510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological and Immunohistochemical Biomarkers in Distinguishing Prostate Carcinoma and Urothelial Carcinoma: A Comprehensive Review.
    Sanguedolce F; Russo D; Mancini V; Selvaggio O; Calò B; Carrieri G; Cormio L
    Int J Surg Pathol; 2019 Apr; 27(2):120-133. PubMed ID: 30509113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors in urothelial carcinoma].
    Vögeli TA; Ackermann R
    Urologe A; 2001 Nov; 40(6):442-6. PubMed ID: 11760346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scoring Systems for Immunohistochemistry in Urothelial Carcinoma.
    Bösherz MS; Samarska IV; Gaisa NT
    Methods Mol Biol; 2023; 2684():3-25. PubMed ID: 37410225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urothelial carcinoma with villoglandular differentiation (UCVGD) with small cell neuroendocrine carcinoma of urinary bladder.
    Jha S; Mitra S; Adhya AK; Nayak P
    BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30661049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-grade Urothelial Carcinoma with Malignant Melanocytic Differentiation.
    Xu H; Genega EM; Zhuang L; Zhou M
    Int J Surg Pathol; 2021 Oct; 29(7):794-797. PubMed ID: 33733892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bladder tumor histoseminar - Case 8: Liver metastasis of urothelial carcinoma].
    Lindner V
    Ann Pathol; 2016 Dec; 36(6):404-409. PubMed ID: 27856062
    [No Abstract]   [Full Text] [Related]  

  • 13. Urothelial carcinoma with squamous differentiation--the pathologists׳ perspective.
    Gellert LL; Warrick J; Al-Ahmadie HA
    Urol Oncol; 2015 Oct; 33(10):437-43. PubMed ID: 26321057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serous Carcinoma Mimicking Primary Urothelial Carcinoma on Clinical Evaluation and Pathology: A Potential Diagnostic Pitfall.
    Mirsadraei L; Hodkoff A; Jones K; Shabaik A; Kader AK; Saenz CC; Montironi R; Tacha DE; Fadare O; Hansel DE
    Arch Pathol Lab Med; 2018 Feb; 142(2):168-177. PubMed ID: 28795841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of concomitant occurrence of solitary fibrous tumor and urothelial high-grade invasive carcinoma of the urinary bladder.
    Spairani C; Squillaci S; Pitino A; Ferrari M; Montefiore F; Rossi C; Fusco W; Bigatti GL
    Int J Surg Pathol; 2014 May; 22(3):252-9. PubMed ID: 23515556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of NANOG in urothelial carcinoma of the bladder.
    Md Akhir MKA; Hussin H; Veerakumarasivam A; Choy CS; Abdullah MA; Abd Ghani F
    Malays J Pathol; 2017 Dec; 39(3):227-234. PubMed ID: 29279584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bladder tumor histo-seminar - case 5: Urothelial carcinoma with squamous differentiation (basal type)].
    Allory Y
    Ann Pathol; 2016 Dec; 36(6):390-393. PubMed ID: 27838080
    [No Abstract]   [Full Text] [Related]  

  • 18. Problems arising in the diagnosis of primary ovarian transitional cell carcinoma after the occurrence of a transitional cell carcinoma of the bladder: a report of a difficult case and a critical review of literature.
    Raspollini MR; Paglierani M; Taddei GL
    Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):178-83. PubMed ID: 19521281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.
    Li WM; Wei YC; Huang CN; Ke HL; Li CC; Yeh HC; Chang LL; Huang CH; Li CF; Wu WJ
    J Surg Oncol; 2016 May; 113(6):700-7. PubMed ID: 26861489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic roles of CK20 in the pathology of urothelial lesions. A systematic review.
    Sanguedolce F; Russo D; Calò B; Cindolo L; Carrieri G; Cormio L
    Pathol Res Pract; 2019 Jun; 215(6):152413. PubMed ID: 30987832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.